A detailed history of Burleson & Company, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Burleson & Company, LLC holds 18,438 shares of MRK stock, worth $1.81 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
18,438
Previous 14,692 25.5%
Holding current value
$1.81 Million
Previous $1.27 Million 61.66%
% of portfolio
0.53%
Previous 0.27%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 30, 2023

BUY
$87.44 - $112.11 $327,550 - $419,964
3,746 Added 25.5%
18,438 $2.05 Million
Q3 2022

Oct 17, 2022

BUY
$84.53 - $94.96 $167,453 - $188,115
1,981 Added 15.58%
14,692 $1.27 Million
Q2 2022

Jul 13, 2022

BUY
$83.49 - $94.64 $834 - $946
10 Added 0.08%
12,711 $1.16 Million
Q1 2022

Apr 25, 2022

SELL
$73.51 - $82.4 $1,323 - $1,483
-18 Reduced 0.14%
12,701 $1.04 Million
Q4 2021

Jan 25, 2022

SELL
$72.28 - $90.54 $11,709 - $14,667
-162 Reduced 1.26%
12,719 $975,000
Q3 2021

Nov 02, 2021

BUY
$71.68 - $78.83 $215 - $236
3 Added 0.02%
12,881 $968,000
Q2 2021

Jul 22, 2021

SELL
$70.31 - $77.77 $36,701 - $40,595
-522 Reduced 3.9%
12,878 $1 Million
Q1 2021

May 12, 2021

SELL
$68.86 - $81.11 $15,700 - $18,493
-228 Reduced 1.67%
13,400 $1.03 Million
Q4 2020

Feb 08, 2021

BUY
$71.77 - $79.65 $23,325 - $25,886
325 Added 2.44%
13,628 $1.12 Million
Q3 2020

Nov 10, 2020

BUY
$73.18 - $82.95 $15,001 - $17,004
205 Added 1.57%
13,303 $1.07 Million
Q2 2020

Aug 13, 2020

SELL
$70.42 - $80.13 $17,957 - $20,433
-255 Reduced 1.91%
13,098 $1.06 Million
Q1 2020

May 15, 2020

BUY
$63.36 - $87.82 $14,826 - $20,549
234 Added 1.78%
13,353 $1.02 Million
Q4 2019

Feb 12, 2020

BUY
$77.58 - $87.54 $77 - $87
1 Added 0.01%
13,119 $1.18 Million
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $39,029 - $42,543
513 Added 4.07%
13,118 $1.09 Million
Q1 2019

May 09, 2019

SELL
$69.58 - $79.36 $10,367 - $11,824
-149 Reduced 1.17%
12,605 $1.01 Million
Q4 2018

Feb 27, 2019

BUY
$65.24 - $75.71 $37,317 - $43,306
572 Added 4.7%
12,754 $1.02 Million
Q3 2018

Dec 06, 2018

BUY
$57.69 - $67.84 $42,863 - $50,405
743 Added 6.5%
12,182 $930,000
Q2 2018

Jul 31, 2018

BUY
$50.83 - $59.72 $155,438 - $182,623
3,058 Added 36.49%
11,439 $694,000
Q1 2018

Apr 23, 2018

SELL
$50.96 - $59.23 $104,417 - $121,362
-2,049 Reduced 19.65%
8,381 $457,000
Q4 2017

Mar 19, 2018

BUY
$51.62 - $61.64 $538,396 - $642,905
10,430
10,430 $587,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Burleson & Company, LLC Portfolio

Follow Burleson & Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burleson & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Burleson & Company, LLC with notifications on news.